{"schema_version":"secwatch.filing_event.v1","accession":"0001558370-24-011193","form_type":"8-K","ticker":"TECH","cik":"0000842023","company_name":"BIO-TECHNE Corp","filed_at":"2024-08-07T23:59:59+00:00","discovered_at":"2026-05-14T18:03:16.026915+00:00","generated_at":"2026-05-31T11:59:35.282935+00:00","sec_items":["2.02","8.01","9.01"],"event_type":"earnings","sentiment":"neutral","materiality_score":0.7,"calibrated_materiality_score":0.7,"confidence":"high","headline":"Bio-Techne Q4 adjusted EPS $0.49 vs $0.55 YoY; revenue $306.1M (+2%)","bullets":["Q4 organic revenue up 1% to $306.1M; FY2024 organic revenue up 1% to $1.2B.","GAAP EPS $0.25 vs $0.47; adjusted EPS $0.49 vs $0.55.","Diagnostics & Genomics segment grew 9% organically in Q4.","FY2024 operating cash flow $299M, up 18% YoY.","Board declared $0.08 quarterly dividend payable Aug 30, record Aug 19."],"urls":{"canonical":"https://secwatch.observer/filing/0001558370-24-011193","json":"https://secwatch.observer/filing/0001558370-24-011193.json","markdown":"https://secwatch.observer/filing/0001558370-24-011193.md","text":"https://secwatch.observer/filing/0001558370-24-011193.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/842023/000155837024011193/0001558370-24-011193-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/842023/000155837024011193/tech-20240807x8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-31T11:59:35.282935+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}